Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5208]
News [15394]
Articles [108]
Editorials [3]
Conferences [263]
elearning [21]
Mesothelioma and the tumour suppressor gene, NF2
Dr Emanuela Felley-Bosco – University Hospital Zurich, Switzerland
Mesothelioma and the tumour suppressor gene, NF2 ( Dr Emanuela Felley-Bosco – University Hospital Zurich, Switzerland )
15 May 2013
Next generation sequencing in oncology
Dr Antonio Marchetti – University-Foundation, Chieti, Italy
Next generation sequencing in oncology ( Dr Antonio Marchetti – University-Foundation, Chieti, Italy )
15 May 2013
Extracellular matrix proteins of stem cell niches promote breast cancer...
Dr Thordur Oskarsson - HI-STEM, Heidelberg, Germany
Extracellular matrix proteins of stem cell niches promote breast cancer metastasis ( Dr Thordur Oskarsson - HI-STEM, Heidelberg, Germany )
15 May 2013
Update on the METABRIC consortium 2000 Breast Cancer Study
Prof Carlos Caldas - University of Cambridge, UK
Update on the METABRIC consortium 2000 Breast Cancer Study ( Prof Carlos Caldas - University of Cambridge, UK )
14 May 2013
The Cancer Genome Atlas (TCGA): comprehensive molecular portraits of breast...
Prof Charles Perou - University of North Carolina School of Medicine, USA
The Cancer Genome Atlas (TCGA): comprehensive molecular portraits of breast cancer ( Prof Charles Perou - University of North Carolina School of Medicine, USA )
14 May 2013
Genetic alterations in postmenopausal women with hormone receptor-positive...
Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium
Genetic alterations in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer ( Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium )
14 May 2013
Gene expression test distinguishes between breast cancer patients at high or...
Prof Michael Gnant - Medical University of Vienna, Austria
Gene expression test distinguishes between breast cancer patients at high or low risk of late recurrence ( Prof Michael Gnant - Medical University of Vienna, Austria )
14 May 2013
Implementation of individualised treatment and the WINTHER trial
Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller
Implementation of individualised treatment and the WINTHER trial ( Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller )
30 Apr 2013
Importance of personalised medicine and the WIN Consortium
Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller
Importance of personalised medicine and the WIN Consortium ( Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller )
30 Apr 2013
The role of physicians and researchers in the medical community
Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller
The role of physicians and researchers in the medical community ( Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller )
30 Apr 2013
Achievements of the WIN Consortium
Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller
Achievements of the WIN Consortium ( Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller )
30 Apr 2013
Goal of the 2013 WIN Symposium
Dr John Mendelsohn, Dr Richard Schilsky, Dr Richard Buller
Goal of the 2013 WIN Symposium ( Dr John Mendelsohn, Dr Richard Schilsky, Dr Richard Buller )
23 Apr 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation